Literature DB >> 30892814

Genotype-phenotype specificity in Menke-Hennekam syndrome caused by missense variants in exon 30 or 31 of CREBBP.

Siddharth Banka1,2, Rebecca Sayer2, Catherine Breen1,2, Stephanie Barton2, Julija Pavaine3,4, Sarah E Sheppard5, Emma Bedoukian6, Cara Skraban5,7, Vishnu A Cuddapah8, Jill Clayton-Smith1,2.   

Abstract

CREBBP loss-of function variants cause Rubinstein-Taybi syndrome (RTS). There have been two separate reports of patients with missense variants in exon 30 or 31 of CREBBP in individuals lacking the characteristic facial and limb dysmorphism associated with RTS. Frequent features in this condition include variable intellectual disability, short stature, autistic behavior, microcephaly, feeding problems, epilepsy, recurrent upper airway infections, and mild hearing impairment. We report three further patients with de novo exon 31 CREBBP missense variants. The first individual has a c.5357G>A p. (Arg1786His) variant affecting the same codon as one of the previously described patients. Both these patients could be recognized by clinicians as mild RTS. Our second patient has a c.5602C>T p.(Arg1868Trp) variant that has been described in five other individuals who all share a strikingly similar phenotype. The third individual has a novel c.5354G>A p.(Cys1785Try) variant. Our reports expand the clinical spectrum to include ventriculomegaly, absent corpus callosum, staphyloma, cochlear malformations, and exomphalos. These additional cases also help to establish genotype-phenotype correlations in this disorder. After the first and last authors of the previous two reports, we propose to call this disorder "Menke-Hennekam syndrome" to establish it as a clinical entity distinct from RTS and to provide a satisfactory name for adoption by parents and professionals, thus facilitating appropriate clinical management and research.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CREBBP; Menke-Hennekam syndrome; Rubinstein-Taybi syndrome

Mesh:

Substances:

Year:  2019        PMID: 30892814     DOI: 10.1002/ajmg.a.61131

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.

Authors:  Nicholas Favalli; Gabriele Bassi; Christian Pellegrino; Jacopo Millul; Roberto De Luca; Samuele Cazzamalli; Su Yang; Anika Trenner; Nour L Mozaffari; Renier Myburgh; Mustafa Moroglu; Stuart J Conway; Alessandro A Sartori; Markus G Manz; Richard A Lerner; Peter K Vogt; Jörg Scheuermann; Dario Neri
Journal:  Nat Chem       Date:  2021-04-08       Impact factor: 24.427

2.  Menke-Hennekam Syndrome: A Literature Review and a New Case Report.

Authors:  Aurora Sima; Roxana Elena Smădeanu; Anca Angela Simionescu; Florina Nedelea; Andreea-Maria Vlad; Cristina Becheanu
Journal:  Children (Basel)       Date:  2022-05-22

3.  A Novel CREBBP in-Frame Deletion Variant in a Chinese Girl with Atypical Rubinstein-Taybi Syndrome Phenotypes.

Authors:  Qingming Wang; Wanfang Xu; Yanhui Liu; Haiming Yuan
Journal:  J Mol Neurosci       Date:  2020-08-25       Impact factor: 3.444

4.  Chiari 1 malformation and exome sequencing in 51 trios: the emerging role of rare missense variants in chromatin-remodeling genes.

Authors:  Aldesia Provenzano; Andrea La Barbera; Mirko Scagnet; Angelica Pagliazzi; Giovanna Traficante; Marilena Pantaleo; Lucia Tiberi; Debora Vergani; Nehir Edibe Kurtas; Silvia Guarducci; Sara Bargiacchi; Giulia Forzano; Rosangela Artuso; Viviana Palazzo; Ada Kura; Flavio Giordano; Daniele di Feo; Marzia Mortilla; Claudio De Filippi; Gianluca Mattei; Livia Garavelli; Betti Giusti; Lorenzo Genitori; Orsetta Zuffardi; Sabrina Giglio
Journal:  Hum Genet       Date:  2020-12-18       Impact factor: 4.132

Review 5.  Reprogramming of the epigenome in neurodevelopmental disorders.

Authors:  Khadija D Wilson; Elizabeth G Porter; Benjamin A Garcia
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-10-02       Impact factor: 8.697

6.  Comprehensive genetic testing improves the clinical diagnosis and medical management of pediatric patients with isolated hearing loss.

Authors:  Jiale Xiang; Yuan Jin; Nana Song; Sen Chen; Jiankun Shen; Wen Xie; Xiangzhong Sun; Zhiyu Peng; Yu Sun
Journal:  BMC Med Genomics       Date:  2022-06-27       Impact factor: 3.622

7.  A Case of Common Variable Immunodeficiency with CREBP Gene Mutation without Rubinstein Taybi Syndrome Features.

Authors:  Ugur Musabak; Serdar Ceylaner; Tuba Erdogan; Ebru Sebnem Ayva
Journal:  Case Reports Immunol       Date:  2022-07-04

8.  TTC5 syndrome: Clinical and molecular spectrum of a severe and recognizable condition.

Authors:  Luciana Musante; Flavio Faletra; Kolja Meier; Hoda Tomoum; Paria Najarzadeh Torbati; Edward Blair; Sally North; Jutta Gärtner; Susann Diegmann; Mehran Beiraghi Toosi; Farah Ashrafzadeh; Ehsan Ghayoor Karimiani; David Murphy; Flora Maria Murru; Caterina Zanus; Andrea Magnolato; Martina La Bianca; Agnese Feresin; Giorgia Girotto; Paolo Gasparini; Paola Costa; Marco Carrozzi
Journal:  Am J Med Genet A       Date:  2022-06-07       Impact factor: 2.578

Review 9.  Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.

Authors:  Julien Van Gils; Frederique Magdinier; Patricia Fergelot; Didier Lacombe
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.